Remy CFO: Chinese officials have given no timeline on EU brandy probe-March 2024-www.financetom.com

Remy CFO: Chinese officials have given no timeline on EU brandy probe

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Remy CFO: Chinese officials have given no timeline on EU brandy probe

Jul 24, 2024 1:03 AM

LONDON, July 24 (Reuters) - Beijing officials have given

no official timeframe for a decision regarding an anti-dumping

investigation into brandy imported from the European Union, Remy

CFO Luca Marotta said on Wednesday.

The maker of Remy Martin cognac and Cointreau liqueur has

made no changes to its Chinese operations in the meantime, he

said.

Previous page： Wright Flood completes the acquisition of Poulton Associates, LLC Next page： AG Mortgage Q3 gets boost from increased Arc Home stake

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Wright Flood completes the acquisition of Poulton Associates, LLC

Nov 4, 2025

CLEARWATER, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Wright National Flood Insurance Company (“Wright Flood”) today announced the completion of the previously announced acquisition of the insurance operations Poulton Associates, LLC. About Wright National Flood Insurance Company Wright Flood, a wholly owned subsidiary of Brown & Brown Inc. ( BRO ), operating within Arrowhead Programs, is the largest flood insurance...

AG Mortgage Q3 gets boost from increased Arc Home stake

Nov 4, 2025

Overview * AG Mortgage Q3 net income was $0.47 per share * Company acquired additional 21.4% interest in Arc Home, increasing ownership to 66% * Earnings available for distribution were $0.23 per share, supported by Arc Home's contribution Outlook * Company did not provide specific guidance for future quarters Result Drivers * ARC HOME CONTRIBUTION - Increased stake in Arc...

MPLX Q3 Adjusted Earnings, Revenue Rise

Nov 4, 2025

06:44 AM EST, 11/04/2025 (MT Newswires) -- MPLX ( MPLX ) reported Q3 adjusted earnings Tuesday of $1.52 per diluted share, up from $1.01 a year earlier. Four analysts polled by FactSet expected $1.08. Revenue for the quarter ended Sept. 30 was $3.62 billion, compared with $2.97 billion a year earlier. Four analysts surveyed by FactSet expected $3.16 billion. ...

Kura Oncology Q3 net loss widens to $74.1 mln

Nov 4, 2025

Overview * Kura Oncology reports Q3 2025 net loss of $74.1 mln, up from $54.4 mln in 2024 * Collaboration revenue for Q3 2025 was $20.8 mln, compared to none in Q3 2024 * Company's ziftomenib program under FDA Priority Review, PDUFA date set for Nov 30, 2025 Outlook * Kura Oncology ( KURA ) expects FDA decision on ziftomenib...